The start of the first trial of the national Zoloft MDL has been delayed. It now is scheduled to begin on January 5, 2015. Defendant Pfizer filed a Motion to Continue asking the presiding judge for more time to prepare for trial. On May 1, 2014, Pfizer’s motion was granted.
The Zoloft Multidistrict Litigation (MDL) against Pfizer currently includes over 475 cases. The suits claim that use of Zoloft in pregnancy caused children to suffer birth defects. The Zoloft MDL is being litigated in the United States District Court in the Eastern District of Pennsylvania in Philadelphia, Hon. Cynthia Rufe presiding. The first trial originally was scheduled to begin on November 3, 2014.
The Court’s Order is set out below:
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
IN RE: ZOLOFT (SERTRALINE
THIS DOCUMENT APPLIES TO:
HON. CYNTHIA M. RUFE
PRETRIAL ORDER NO. 57
(Amending Pretrial Order Nos. 39, 44, and 56)
AND NOW, this 1st day of May 2014, upon consideration of Defendants’ Motion to
Amend Pretrial Orders Nos. 39, 44, and 56 to Extend Trial Schedule [Doc. No. 806] and the
response thereto, and after telephone conferences with counsel and the Special Discovery Master,
and it is hereby ORDERED that the Motion is GRANTED as follows: The Court anticipates
that the first trial will begin on or about January 5, 2015, instead of November 3, 2014. The
parties shall confer and submit a proposed revised schedule in light of the new trial date.
It is so ORDERED.
BY THE COURT:
CYNTHIA M. RUFE, J.